| Sanofi-Aventis (Suisse) SA - VaxigripTetra, Suspension pour injection dans une seringue pré-remplie | | 66427 | | 05 | | VaxigripTetra | | Suspension pour injection dans une seringue pré-remplie | | J07BB02 | | Influenza, Inactivated, Split Virus Or Surface Antigen | | 11.08.2021 | | |
| | Composition | | haemagglutininum influenzae A (H1N1) (Virus souche A/Victoria/2570/2019 (H1N1)-pdm09: reassortant virus IVR-215 derived from A/Victoria/2570/2019) 15 µg, haemagglutininum influenzae A (H3N2) (Virus souche A/Cambodia/e0826360/2020 (H3N2)-like: reassortant virus IVR-221 derived from A/Cambodia/e0826360/2020) 15 µg, haemagglutininum influenzae B (Virus souche B/Washington/02/2019 (Victoria lineage)) 15 µg, haemagglutininum influenzae B (Virus souche B/Phuket/3073/2013 (Yamagata lineage)) 15 µg, natrii chloridum, kalii chloridum, dinatrii phosphas dihydricus, kalii dihydrogenophosphas, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml corresp. natrium 1.72 mg, kalium 0.08 mg, residui: formaldehydum, octoxinolum-9, neomycinum, ovalbuminum. | | Packungsbestandteile | | | | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| No entries have been found. |
|
|
